0001567619-21-004324.txt : 20210217 0001567619-21-004324.hdr.sgml : 20210217 20210217193120 ACCESSION NUMBER: 0001567619-21-004324 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210214 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lane Michael CENTRAL INDEX KEY: 0001740689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 21647007 MAIL ADDRESS: STREET 1: C/O IDEXX LABORATORIES, INC. CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2021-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001740689 Lane Michael C/O IDEXX LABORATORIES, INC. ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President Common Stock 2021-02-14 4 M 0 221 0 A 4005 D Common Stock 2021-02-14 4 M 0 212 0 A 4217 D Common Stock 2021-02-14 4 M 0 196 0 A 4413 D Common Stock 2021-02-14 4 M 0 181 0 A 4594 D Common Stock 2021-02-14 4 M 0 174 0 A 4768 D Common Stock 2021-02-14 4 F 0 314 544.08 D 4474 D Common Stock 2021-02-16 4 S 0 850 545 D 3624 D Common Stock 592 I by spouse Non-Qualified Stock Option (right-to-buy) 544.08 2021-02-14 4 A 0 6003 A 2031-02-13 Common Stock 6003 6003 D Incentive Stock Option (right-to-buy) 544.08 2021-02-14 4 A 0 183 A 2031-02-13 Common Stock 183 183 D Restricted Stock Unit 2021-02-14 4 A 0 643 A Common Stock 643 3292 D Restricted Stock Unit 2021-02-14 4 M 0 221 D Common Stock 221 3071 D Restricted Stock Unit 2021-02-14 4 M 0 212 D Common Stock 212 2859 D Restricted Stock Unit 2021-02-14 4 M 0 196 D Common Stock 196 2663 D Restricted Stock Unit 2021-02-14 4 M 0 181 D Common Stock 181 2482 D Restricted Stock Unit 2021-02-14 4 M 0 174 D Common Stock 174 2308 D Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein. Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Michael Lane 2021-02-17